Some sections appear to be highly speculative (e.g
"Ricky" Bass III, MD, MS, MPH, is dual board-certified in Internal Medicine and Pediatrics
S., Thomas, R., Mohamed, R., & Wajda, S
Zepbound tirzepatide injection, solution, DailyMed (2025) Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity the SURMOUNT-4 randomized clinical trial, JAMA (2023) Tirzepatide, StatPearls [Internet] (2024) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Patients receiving the 2.4 mg weekly dose (Wegovy) for weight management may experience more pronounced digestive effects compared to those on lower doses used for diabetes management
Cuomo, MPH, PhD, the author of the study and a professor of medicine at the University of California in San Diego